Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fabian, Riegg"'
Autor:
Melanie Märklin, Gundram Jung, Martin Pflügler, Helmut R Salih, Latifa Zekri, Martina S Lutz, Bastian Schmied, Fabian Riegg
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/69f50bdfe688453ba50e2063ad4ff985
Autor:
Amporn Atsawarungruangkit, Jin Yuan, Takamitsu Kodama, Ming-Tai Cheng, Mohammad Mansouri, Boram Han, Jarinrat Kongkamnerd, Fabian Riegg, Anupama Menon, Steven F. Moss
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Background The outbreak of coronavirus disease 2019 (COVID-19) began in December 2019 and continues to spread worldwide. Rapid and accurate identification of suspected cases is critical in slowing spread of the virus that causes the disease. We aimed
Externí odkaz:
https://doaj.org/article/d304e7c18d6f4fe6b77b9544e1f48d58
Autor:
Fabian Riegg, Martina S. Lutz, Bastian J. Schmied, Jonas S. Heitmann, Manon Queudeville, Peter Lang, Gundram Jung, Helmut R. Salih, Melanie Märklin
Publikováno v:
Cancers
Volume 13
Issue 7
Cancers, Vol 13, Iss 1632, p 1632 (2021)
Volume 13
Issue 7
Cancers, Vol 13, Iss 1632, p 1632 (2021)
In recent decades, antibody-dependent cellular cytotoxicity (ADCC)-inducing monoclonal antibodies (mAbs) have revolutionized cancer immunotherapy, and Fc engineering strategies have been utilized to further improve efficacy. A promising option is to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4ada29510ec79e14e3f0a31e57fe1373
https://pubmed.ncbi.nlm.nih.gov/33915811
https://pubmed.ncbi.nlm.nih.gov/33915811
Autor:
Martina S. Lutz, Bastian J. Schmied, Fabian Riegg, Latifa Zekri, Jonas S. Heitmann, Melanie Maerklin, Martin Pfluegler, Gundram Jung, Helmut R. Salih
Publikováno v:
Cancer Research. 82:2860-2860
After diagnosis, a primary goal of treatment in acute myeloid leukemia (AML) is to achieve a morphological complete remission (CR) by induction chemotherapy. However, about half of the patients in CR show remaining minimal residual disease (MRD), whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2aa5cb8ca54f3a9d6a3c28749f0a202d
https://doi.org/10.1158/1538-7445.am2022-2860
https://doi.org/10.1158/1538-7445.am2022-2860
Autor:
Fabian Riegg, Steven F. Moss, Mohammad Mansouri, Jarinrat Kongkamnerd, Jin Yuan, Amporn Atsawarungruangkit, Anupama Menon, Takamitsu Kodama, Ming-Tai Cheng, Boram Han
Publikováno v:
The Journal of International Medical Research
Journal of International Medical Research, Vol 48 (2020)
Journal of International Medical Research, Vol 48 (2020)
Background The outbreak of coronavirus disease 2019 (COVID-19) began in December 2019 and continues to spread worldwide. Rapid and accurate identification of suspected cases is critical in slowing spread of the virus that causes the disease. We aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46aa9209d806dd018ab0495198239477
http://europepmc.org/articles/PMC7469754
http://europepmc.org/articles/PMC7469754
Autor:
Bastian J, Schmied, Martina S, Lutz, Fabian, Riegg, Latifa, Zekri, Jonas S, Heitmann, Hans-Jörg, Bühring, Gundram, Jung, Helmut R, Salih
Publikováno v:
Cancers
Antibody-dependent cellular cytotoxicity (ADCC) is a major mechanism by which antitumor antibodies mediate therapeutic efficacy. At present, we evaluate an Fc-optimized (amino acid substitutions S239D/I332E) FLT3 antibody termed 4G8-SDIEM (FLYSYN) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d5ae6dc491f9186effe05075d8eda04e
https://pubmed.ncbi.nlm.nih.gov/31817795
https://pubmed.ncbi.nlm.nih.gov/31817795